找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Handbook of Cystic Fibrosis; Amy G. Filbrun,Thomas Lahiri,Clement L Ren Book 2016 Springer International Publishing Switzerland 2016 CFTR

[復制鏈接]
樓主: EVOKE
21#
發(fā)表于 2025-3-25 06:08:02 | 只看該作者
The Rise of Effective Treatments, of CF care has become even brighter with the development of CFTR modulators; medications that can target the underlying defect causing CF. Currently available CFTR modulators target only a small proportion of patients with CF or lack potency, although, newer more effective compounds are under devel
22#
發(fā)表于 2025-3-25 11:23:44 | 只看該作者
23#
發(fā)表于 2025-3-25 14:45:05 | 只看該作者
,Uniqueness of meromorphic functions on ?,tic fibrosis transmembrane conductance regulator (CFTR) modulator therapies heralds a new era in CF care, their full impact on CF remains to be determined, and older patients with CF are likely to still have complications of CF that need to be addressed.
24#
發(fā)表于 2025-3-25 17:42:00 | 只看該作者
25#
發(fā)表于 2025-3-25 22:20:02 | 只看該作者
26#
發(fā)表于 2025-3-26 02:14:12 | 只看該作者
Bernhard Kramann,Manfred SchmelingCystic fibrosis (CF) is a multisystem disease, and its clinical features reflect the broad impact that loss of cystic fibrosis transmembrane conductance regulator (CFTR) function has on multiple organs (Fig. .). However, pulmonary and gastrointestinal disease account for the vast majority of morbidity and mortality in CF.
27#
發(fā)表于 2025-3-26 07:35:15 | 只看該作者
Clinical Features and Complications of Cystic Fibrosis,Cystic fibrosis (CF) is a multisystem disease, and its clinical features reflect the broad impact that loss of cystic fibrosis transmembrane conductance regulator (CFTR) function has on multiple organs (Fig. .). However, pulmonary and gastrointestinal disease account for the vast majority of morbidity and mortality in CF.
28#
發(fā)表于 2025-3-26 12:23:36 | 只看該作者
Amy G. Filbrun,Thomas Lahiri,Clement L RenConcise yet complete overview of the epidemiology, pathophysiology, and clinical features of cystic fibrosis and an in-depth review of the most up-to-date methods of diagnosis, symptom management, and
29#
發(fā)表于 2025-3-26 12:56:43 | 只看該作者
http://image.papertrans.cn/h/image/421123.jpg
30#
發(fā)表于 2025-3-26 20:41:00 | 只看該作者
https://doi.org/10.1007/978-3-319-32504-0CFTR mutations; Cystic Fibrosis; Cystic Fibrosis manifestations; Pulmonary; Respiratory medicine
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學 Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點評 投稿經(jīng)驗總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學 Yale Uni. Stanford Uni.
QQ|Archiver|手機版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-8 09:10
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復 返回頂部 返回列表
休宁县| 神池县| 武强县| 金华市| 郑州市| 安国市| 永宁县| 泰顺县| 墨竹工卡县| 广德县| 长宁县| 卫辉市| 建德市| 武威市| 玉山县| 日土县| 汶上县| 宁都县| 个旧市| 云和县| 随州市| 连平县| 襄汾县| 三门县| 台州市| 晋城| 永新县| 荆州市| 禹州市| 临桂县| 阿拉善左旗| 万年县| 微博| 赤水市| 大新县| 永春县| 清河县| 广宗县| 莒南县| 南涧| 渝中区|